Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$61.3K Hold
1,273
– – 0.05% 221
2026
Q2
$66.7K Hold
1,273
– – 0.05% 208
2026
Q1
$70.3K Hold
1,273
– – 0.06% 204
2025
Q4
$62.4K Buy
+1,273
New +$59.4K 0.06% 206

Other funds holding GSK

Bayban's GSK Position: Q3 2026 in Review

Bayban held its GSK (GSK) position steady in Q3 2026 at 1,273 shares worth $61.3K. The position accounts for 0.05% of the portfolio, ranked #221.

Bayban first reported a position in GSK in Q4 2025 and has held it in 4 quarters since. The position peaked at $70.3K in Q1 2026. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Bayban held 1,273 shares of GSK worth $61.3K as of Q3 2026.
  • Bayban left its GSK share count unchanged in Q3 2026.
  • GSK made up 0.05% of Bayban's portfolio in Q3 2026, its #221 holding.
  • Bayban first reported a position in GSK in Q4 2025 and has held it in 4 quarters since.
  • Bayban's GSK position peaked at $70.3K in Q1 2026.
  • 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.